Search Results 211-220 of 16679 for ������������KA���:ZA31���24������ ���������������������������������

  1. A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) - Mayo Clinic

    ... 24 hours (for a urine test) or 72 hours (for a serum test) before the first dose of study intervention, medical history, menstrual history, and recent ...

  2. Decision Aids for Patients with Nonvalvular Chronic Atrial Fibrillation - Mayo Clinic

    Madeleine M; Cameron KA. Kenzie A; Cavanaugh KL. Kerri L; Steinberg BA. Benjamin A; Passman R. Rod; Kansal P. Preeti; Guzman A. Adriana; Chen E. Emily ...

  3. MBRT1 - Mayo Clinic

    Rochester, Minnesota: 24-004810. NCT ID: NCT07062003. Sponsor Protocol Number: GMROR2471. About this study. This is a dose-finding trial with the aim of ...

  4. https://www.mayoclinic.org/chinese_organization_concepts.xml

    ... 24-05:00</lastmod><xhtml:link rel="alternate" hreflang="ar" href="https://www.mayoclinic.org/ar/departments-centers/cardiovascular-medicine/sections ...

  5. Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI) - Mayo Clinic

    ... 24 hours after randomization 6. Weight is less than 40 kg or more than 125 ... 24 hours) 8. Sepsis diagnosis according to sepsis inclusion criteria for ...

  6. Investigations of Reproductive Cancers in Women (PROACTION:) - Mayo Clinic

    Rochester, Minnesota: 24-005919. NCT ID: NCT06527157. Sponsor Protocol Number: PNK002. About this study. The purpose of this study is to validate a non-invasive ...

  7. https://www.mayoclinic.org/arabic_condition_consolidated_concepts.xml

    ... 24-05:00</lastmod><xhtml:link rel="alternate" hreflang="en" href="https://www.mayoclinic.org/diseases-conditions/brain-tumor/doctors-departments/ddc ...

  8. Publications - Katie L. Johnson, M.D. - Mayo Clinic

    ... KA. The spectrum of concern for medical child ... KA. The overlap of medical child abuse and central ... 2021 Sep 24; 10775595211041974 Epub 2021 Sept 24

  9. ... 24,24, 300000000,HC 2D6 SEQUENCING,548,548, 300000002,HC 5-HTT GENE ANALYSIS,338,338, 300000004,HC ABL1 KD VARIANTS,705,850, 300000005,HC ACADS KNOWN ...

  10. A Study to Evaluate CC-98633 to Treat Subjects with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    Less differentiated T cells have shown an increased ability to proliferate, persist, and mediate responses in mouse tumor models compared to more differentiated ...